Risperidone
- Product NDC
- 51991-716
- 11-digit product format
- 519910716
- Labeler code
- 51991
- Product ID
- 51991-716_0201ab4c-576d-41d1-8b45-4f6375386a2b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Risperidone
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Breckenridge Pharmaceutical, Inc.
- Application
- ANDA079059
- Marketing category
- ANDA
- Marketing start
- 2014-01-29
- Marketing end
- 2020-11-30
- Substance
- RISPERIDONE
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 51991-716 | D | Discontinued by firm | 2026-07-31 | ||
| excluded package | package | 51991-716 | 51991-716-41 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A079059-001 | RISPERIDONE | RISPERIDONE | 1MG/ML | SOLUTION / ORAL | AA | 2012-12-12 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A079059-001 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A079059-001 | RISPERIDONE | 1MG/ML | SOLUTION / ORAL | AA | 2012-12-12 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A079059-001 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Risperidone | RISPERIDONE | ATLANTIC BIOLOGICALS CORP. | dc8c6638-f487-49df-a265-78caa93e43d8 | 2026-07-10 | Boxed warning, Warnings, Adverse reactions | 079059 ANDA079059 |
| Risperidone | RISPERIDONE | REMEDYREPACK INC. | 8a4158fe-37d4-4c97-9c44-1c3489fe2a9f | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | 079059 ANDA079059 |
| Risperidone | RISPERIDONE | Bryant Ranch Prepack | 4604052d-dbda-4535-b7b8-1bd72a129aca | 2025-07-29 | Boxed warning, Warnings, Adverse reactions | 079059 ANDA079059 |
| Risperidone | RISPERIDONE | Cranbury Pharmaceuticals, LLC | a0a21bec-68f0-444e-a611-d0602859410c | 2025-05-05 | Boxed warning, Warnings, Adverse reactions | 079059 ANDA079059 |
| Risperidone | RISPERIDONE | Bryant Ranch Prepack | 3cc027f0-3462-4a2f-925b-d8a529bcb3c3 | 2025-03-21 | Boxed warning, Warnings, Adverse reactions | 079059 ANDA079059 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Risperidone | ACTIVE INGREDIENT | L6UH7ZF8HC | RISPERIDONE SOLUTION [BRECKENRIDGE PHARMACEUTICAL, INC.] | 2 | |
| Risperidone | ACTIVE MOIETY | L6UH7ZF8HC | RISPERIDONE SOLUTION [BRECKENRIDGE PHARMACEUTICAL, INC.] | 2 | |
| Benzoic Acid | INACTIVE INGREDIENT | 8SKN0B0MIM | RISPERIDONE SOLUTION [BRECKENRIDGE PHARMACEUTICAL, INC.] | 2 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | RISPERIDONE SOLUTION [BRECKENRIDGE PHARMACEUTICAL, INC.] | 2 | |
| Sorbitol | INACTIVE INGREDIENT | 506T60A25R | RISPERIDONE SOLUTION [BRECKENRIDGE PHARMACEUTICAL, INC.] | 2 | |
| Tartaric Acid | INACTIVE INGREDIENT | W4888I119H | RISPERIDONE SOLUTION [BRECKENRIDGE PHARMACEUTICAL, INC.] | 2 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | RISPERIDONE SOLUTION [BRECKENRIDGE PHARMACEUTICAL, INC.] | 2 |